|
Synonyms|Editors|Languages|Comments|Home|Sponsors|Health Information |
General
Prevention
- Interagency Agreement Transfers DoD HIV Research to NIAID
- CIPRA -- Comprehensive International Program of Research on AIDS
- NIAID Global Health Research Plan for HIV/AIDS, Malaria, and Tuberculosis
- How HIV Causes AIDS
- Evidence that HIV Causes AIDS
- HIV Infection in Adolescents
- HIV/AIDS Statistics
- HIV Infection and AIDS: An Overview
- HIV Infection in Minority Populations
- HIV Infection in Infants and Children
- The Relationship Between HIV and AIDS
- HIV Infection in Women
Vaccines
- NIAID's HIV Prevention Trials Network (HPTN)
- Inexpensive AIDS Drug Still Reduces HIV Transmission from Mother to Child After One Year
- Topical Microbicides Research
Therapies
- HIV Vaccines Questions and Answers For HIV Treatment Advocates
- HIV Vaccines Questions and Answers For HIV Prevention Workers
- HIV Vaccines Explained -- Making HIV Vaccines a Reality
- First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial
- Fauci to Present AIDS Vaccine Update at Philadelphia Meeting
- NIAID's HIV Vaccine Trials Network (HVTN)
- Resources for HIV Vaccine Research and Development
- Challenges in Designing HIV Vaccines
- Clinical Research on HIV Vaccines
- HIV Vaccine Glossary
- Adult AIDS Clinical Trials Units
- Chemokines and HIV Coreceptors: Opening Doors to New Anti-HIV Strategies
- Community Programs for Clinical Research on AIDS
- Mother-to-Infant HIV Transmission Rate Less Than 2% in Phase III Perinatal Trial (PACTG 316)
- New Treatments for HIV Infection: Prolonging and Improving Life
- Pediatric AIDS Clinical Trials Units
- Treatment of HIV Infection
Other Links
Disclaimer: The National Institute of Allergy and Infectious Diseases does not assume responsibility for information obtained beyond this point. All hyperlinks accessible below are outside of our domain. Please click the "Back" button of your browser to return to this page.
Centers for Disease Control and Prevention (CDC)